NZ222765A - Azole derivatives and pharmaceutical compositions - Google Patents
Azole derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ222765A NZ222765A NZ222765A NZ22276587A NZ222765A NZ 222765 A NZ222765 A NZ 222765A NZ 222765 A NZ222765 A NZ 222765A NZ 22276587 A NZ22276587 A NZ 22276587A NZ 222765 A NZ222765 A NZ 222765A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- acid addition
- addition salt
- pharmaceutically acceptable
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3641320 | 1986-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ222765A true NZ222765A (en) | 1990-11-27 |
Family
ID=6315380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ222765A NZ222765A (en) | 1986-12-03 | 1987-12-01 | Azole derivatives and pharmaceutical compositions |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPH0678318B2 (cs) |
| KR (1) | KR880007481A (cs) |
| AT (1) | AT395587B (cs) |
| AU (1) | AU605522B2 (cs) |
| BE (1) | BE1001235A4 (cs) |
| CH (1) | CH677925A5 (cs) |
| DK (1) | DK631287A (cs) |
| ES (1) | ES2010235A6 (cs) |
| FI (1) | FI875300L (cs) |
| FR (1) | FR2607810B1 (cs) |
| GB (1) | GB2199579B (cs) |
| GR (1) | GR871897B (cs) |
| HU (1) | HU198694B (cs) |
| IL (1) | IL84665A (cs) |
| IT (1) | IT1211944B (cs) |
| LU (1) | LU87063A1 (cs) |
| MY (1) | MY103004A (cs) |
| NL (1) | NL8702897A (cs) |
| NZ (1) | NZ222765A (cs) |
| PH (1) | PH24666A (cs) |
| PL (1) | PL151588B1 (cs) |
| PT (1) | PT86255B (cs) |
| SE (1) | SE8704792L (cs) |
| ZA (1) | ZA879093B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814277D0 (en) * | 1988-06-16 | 1988-07-20 | Glaxo Group Ltd | Chemical compounds |
| TW225526B (cs) * | 1991-09-02 | 1994-06-21 | Yamanouchi Pharma Co Ltd | |
| GB9409882D0 (en) * | 1994-05-18 | 1994-07-06 | Sandoz Ltd | Organic compounds |
| GB0128415D0 (en) * | 2001-11-27 | 2002-01-16 | Univ Sheffield | Medicaments |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT382868B (de) * | 1983-03-11 | 1987-04-27 | Sandoz Ag | Verfahren zur herstellung neuer azolderivate und deren salze |
| JPH0625144B2 (ja) * | 1986-02-24 | 1994-04-06 | 四国化成工業株式会社 | 新規イミダゾール化合物及び該化合物の合成方法 |
-
1987
- 1987-11-26 CH CH4607/87A patent/CH677925A5/de not_active IP Right Cessation
- 1987-11-30 GB GB8727978A patent/GB2199579B/en not_active Expired - Lifetime
- 1987-12-01 DK DK631287A patent/DK631287A/da not_active Application Discontinuation
- 1987-12-01 IT IT8748656A patent/IT1211944B/it active
- 1987-12-01 MY MYPI87003136A patent/MY103004A/en unknown
- 1987-12-01 FI FI875300A patent/FI875300L/fi not_active IP Right Cessation
- 1987-12-01 NZ NZ222765A patent/NZ222765A/en unknown
- 1987-12-01 SE SE8704792A patent/SE8704792L/xx not_active Application Discontinuation
- 1987-12-01 PH PH36145A patent/PH24666A/en unknown
- 1987-12-01 IL IL84665A patent/IL84665A/xx unknown
- 1987-12-01 AU AU81962/87A patent/AU605522B2/en not_active Ceased
- 1987-12-02 AT AT0316887A patent/AT395587B/de not_active IP Right Cessation
- 1987-12-02 NL NL8702897A patent/NL8702897A/nl not_active Application Discontinuation
- 1987-12-02 HU HU875414A patent/HU198694B/hu unknown
- 1987-12-02 KR KR870013695A patent/KR880007481A/ko not_active Ceased
- 1987-12-02 JP JP62305522A patent/JPH0678318B2/ja not_active Expired - Lifetime
- 1987-12-02 FR FR878716736A patent/FR2607810B1/fr not_active Expired
- 1987-12-02 PT PT86255A patent/PT86255B/pt not_active IP Right Cessation
- 1987-12-02 BE BE8701375A patent/BE1001235A4/fr not_active IP Right Cessation
- 1987-12-02 PL PL1987269180A patent/PL151588B1/pl unknown
- 1987-12-03 ES ES8703470A patent/ES2010235A6/es not_active Expired
- 1987-12-03 ZA ZA879093A patent/ZA879093B/xx unknown
- 1987-12-03 LU LU87063A patent/LU87063A1/fr unknown
- 1987-12-14 GR GR871897A patent/GR871897B/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5567831A (en) | Non-steroidal sulfatase inhibitor compounds and their method of use | |
| US5281587A (en) | Steroid sulphatase inhibitors | |
| US5830886A (en) | Steroid sulphatase inhibitors | |
| SU988190A3 (ru) | Способ получени гидантоина | |
| TW442286B (en) | New therapeutic uses of estrogen agonists | |
| CZ105696A3 (en) | Benzophenones and the like compounds as estrogen antagonists | |
| US6433000B1 (en) | Compounds for the treatment of estrogen-dependent illnesses and methods of making and using the same | |
| US6670353B2 (en) | Oxime-group containing oestrone sulphatase inhibitors | |
| RU2001911C1 (ru) | Способ получени замещенных 1,2,3,4-тетрагидронафталинов или их фармацевтически приемлемых аддитивных солей кислоты | |
| Abul-Hajj | Synthesis and evaluation of 4-(substituted thio)-4-androstene-3, 17-dione derivatives as potential aromatase inhibitors | |
| NZ222765A (en) | Azole derivatives and pharmaceutical compositions | |
| CA1211050A (en) | Aromatase inhibiting pyrimidine derivatives | |
| US4609666A (en) | Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles | |
| US4560695A (en) | Isoxazolyl and isothiazolyl aromatase inhibitors | |
| US4762836A (en) | Aromatase inhibitors | |
| US4774251A (en) | Method of inhibiting aromatase | |
| PT95196A (pt) | Processo para a prparacao de n-benziltropanamidas | |
| US4661508A (en) | Aromatase inhibiting α,α-diphenyl-4(5)imidazole-methanes or -ethanes | |
| PT86513B (pt) | Processo de preparacao de inibidores de dopamina-beta-hidroxilase | |
| Zimmermann et al. | Estrogenic and antiestrogenic activities of 2, 4-diphenylfuran-based ligands of estrogen receptors α and β | |
| JPH0680041B2 (ja) | ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬 | |
| US4636496A (en) | Compositions inhibiting murine MXT ductal carcinoma | |
| US7098199B2 (en) | Steroid sulphatase inhibitors | |
| US4767770A (en) | Method of inhibiting aromatase | |
| IL42949A (en) | Pharmaceutical compositions containing indole n-acyl-3 (trichloroethyl) acetate |